NCT03544411

Brief Summary

This study determines the effect of olive oil and bran oil on antioxidant levels, and glycemic control in patients with type 2 diabetes mellitus (DM) Intervention: Patient type 2 DM will receive olive oil and bran oil with cross over study

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for phase_1 diabetes-mellitus-type-2

Timeline
Completed

Started Jul 2018

Shorter than P25 for phase_1 diabetes-mellitus-type-2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 19, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 1, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

July 2, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2018

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 5, 2018

Completed
Last Updated

October 16, 2018

Status Verified

October 1, 2018

Enrollment Period

3 months

First QC Date

May 19, 2018

Last Update Submit

October 13, 2018

Conditions

Keywords

Olive oilBran oilType 2 Diabetes MellitusAntioxidantglycemic controllipid profile

Outcome Measures

Primary Outcomes (1)

  • Change of malondialdehyde

    Change from baseline malondialdehyde at 4 weeks and at 10 weeks, is measured in pmol/mL

    baseline at Day0 and ,midline at Day28 and endline at Day70

Secondary Outcomes (9)

  • Change of fasting plasma glucose

    baseline at Day0 and ,midline at Day28 and endline at Day70

  • Change of post prandial blood glucose

    baseline at Day0 and ,midline at Day28 and endline at Day70

  • Change of total cholesterol

    baseline at Day0 and ,midline at Day28 and endline at Day70

  • Change of Low density lipoprotein

    baseline at Day0 and ,midline at Day28 and endline at Day70

  • Change of High density lipoprotein

    baseline at Day0 and ,midline at Day28 and endline at Day70

  • +4 more secondary outcomes

Study Arms (2)

Type 2 Diabetes Mellitus group 1

EXPERIMENTAL

The group supplemented with 15 ml / day of olive oil and 15 ml / day of bran oil

Biological: olive oilBiological: bran oil

Type 2 Diabetes Mellitus group 2

EXPERIMENTAL

this group supplemented with 15 ml / day of olive oil and 15 ml / day of bran oil

Biological: olive oilBiological: bran oil

Interventions

olive oilBIOLOGICAL

the intervention consist of 15 ml / day of olive oil

Type 2 Diabetes Mellitus group 1Type 2 Diabetes Mellitus group 2
bran oilBIOLOGICAL

the intervention consist of 15 ml / day of bran oil

Type 2 Diabetes Mellitus group 1Type 2 Diabetes Mellitus group 2

Eligibility Criteria

Age30 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with type 2 diabetes aged 30-60 years.
  • Diagnosed type 2 DM \<3 years.
  • Body mass index of 20-30 kg / m2
  • Subjects willing to participate in research and sign informed consent.
  • Drinking OHO (oral hyperglycemic medication).

You may not qualify if:

  • There are acute and chronic complications.
  • Subject is pregnant.
  • Get cholesterol-lowering drugs, steroids and other drugs that affect the metabolism of fat.
  • Smoking more than 10 cigarettes / day.
  • Eat regular supplements that contain phytosterols or other antioxidants that are known by anamnesis.
  • Has a disorder or gastrointestinal disease, thyroid, heart, liver, cancer, stroke and kidney are known with medical record data.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fkui-Kdk Kiara

Jakarta Pusat, DKI Jakarta, 10430, Indonesia

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Lipid Metabolism Disorders

Interventions

Olive OilRice Bran Oil

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Dietary Fats, UnsaturatedDietary FatsFatsLipidsFats, UnsaturatedPlant OilsOilsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesPlant PreparationsBiological ProductsComplex Mixtures

Study Officials

  • Dwirini R Gunarti, DR

    Indonesia University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: This study was a clinical trial with cross over study design, random allocation, and double blindness to compare changes in antioxidant, glucose, cholesterol and triglyceride levels supplemented with 15 ml / day of olive oil (KZ) with supplementation of 15 ml / day of bran oil (KB). Provision of oil for 4 weeks in a row. During the 2-week interval not being treated (wash out). After the wash out period cross-over by exchanging olive oil supplementation to rice bran and vice versa for 4 consecutive weeks.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Human Nutrition Research Centre

Study Record Dates

First Submitted

May 19, 2018

First Posted

June 1, 2018

Study Start

July 2, 2018

Primary Completion

September 20, 2018

Study Completion

October 5, 2018

Last Updated

October 16, 2018

Record last verified: 2018-10

Locations